Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer
Chengfei Liu(UC Davis Comprehensive Cancer Center), Liangren Liu(Sichuan University)
Cited by 0
Related Papers
Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment
|Journal for ImmunoTherapy of Cancer|2023|64
Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models
|Pharmacological Research|2023|20
Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer
|Oncogene|2023|18